Prøve GULL - Gratis
Remote diagnostics greatly influence the accessibility and quality of healthcare
Bio Spectrum
|BioSpectrum Indian Feb 2025
The healthcare industry has undergone tremendous change thanks to remote diagnostics. These enable healthcare providers to provide diagnostic services to patients in even the most remote locations by utilising digital tools and telecommunication technologies. The accessibility and quality of healthcare will be significantly impacted by remote diagnostics, but to assure universal use, a few problems must be resolved.
-

T The diagnostics industry in India is growing rapidly, driven by growing healthcare awareness, an increasing prevalence of chronic diseases and lifestyle disorders, and advancements in technology. It encompasses pathology labs, imaging centres, and specialised diagnostic services - all of which contribute significantly to the healthcare sector.
Key trends in this area include the adoption of digital diagnostics, AI-powered tools, point-ofcare testing, and a surge in home-based diagnostic services and telemedicine. Despite regulatory hurdles and infrastructure gaps, the Indian diagnostics market is poised for substantial growth, improving accessibility and quality of healthcare across the country.
Recent technology developments, particularly in remote diagnostics, have significantly altered the healthcare landscape. These allow medical professionals to reach patients in even the most remote areas using digital tools and telecommunication technologies to deliver diagnostic services. Remote diagnostics will have a significant impact on healthcare accessibility and quality, but there are certain issues that need to be addressed to ensure widespread adoption.
Impact of Remote Diagnostics on Healthcare Accessibility
One of the most significant benefits of remote diagnostics is improving accessibility of healthcare services to the underserved and vulnerable populations such as elderly people, immobile, disabled individuals, and residents of less economically developed areas. In many rural and remote regions of India, people have limited access to healthcare and specialised doctors. Distant diagnostics bridges the gap by providing patients with timely diagnostic services, eliminating the need to travel long distances in emergent situations.
Denne historien er fra BioSpectrum Indian Feb 2025-utgaven av Bio Spectrum.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Bio Spectrum

Bio Spectrum
India's Pharma Reforms Target Global Credibility
The Indian government has introduced several measures to simplify drug approvals and support innovation.
9 mins
October 2025

Bio Spectrum
How Waste Management Strategies Can Transform Indian Pharma Manufacturing
Sustainability will be a key success factor as India's pharmaceutical industry enters its next stage of expansion.
7 mins
October 2025

Bio Spectrum
IASST synthesises new compound to combat aggressive breast cancer
A newly designed nitro-substituted organoselenium compound by Guwahati-based Institute of Advanced Study in Science and Technology (IASST), an autonomous institute under the Department of Science and Technology (DST), can reduce the invasiveness of aggressive triplenegative breast cancer cells by modulating various Se Se signalling pathways.
1 min
October 2025
Bio Spectrum
DPIIT signs MoU with Pfizer to strengthen healthcare innovation ecosystem
In a significant step towards strengthening India's healthcare innovation ecosystem, the Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, has signed a Memorandum of Understanding (MoU) with Pfizer Limited.
1 min
October 2025

Bio Spectrum
WHO unveils updated guideline on HIV service delivery
WHO has released an updated guideline to support integrated HIV service delivery, promote long-term adherence to antiretroviral therapy (ART), and improve the overall health and well-being of people living with HIV.
1 min
October 2025
Bio Spectrum
Scientists in Kolkata explore therapeutic potential of accessory proteins
A hidden protein that protects our cells from mechanical stress could provide a new direction to therapeutic strategies for diseases where protein stability under force is compromised like heart muscle disease or genetic disorders called laminopathies.
1 min
October 2025

Bio Spectrum
US FDA advances rare disease drug development
The US Food and Drug Administration (FDA) has introduced the Rare Disease Evidence Principles (RDEP) to provide greater speed and predictability in the review of therapies intended to treat rare diseases with very small patient populations with significant unmet medical need and that are driven by a known genetic defect.
1 min
October 2025
Bio Spectrum
WHO updates list of essential medicines to include key cancer, diabetes treatments
The World Health Organization (WHO) has released updated editions of its Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLC), adding new treatments for various types of cancer and for diabetes with associated comorbidities such as obesity.
1 min
October 2025
Bio Spectrum
Agilent's MMR IHC Panel pharmDx (Dako Omnis) receives European IVDR Certification
Agilent Technologies Inc. has announced that its MMR IHC Panel pharmDx (Dako Omnis) has received class C companion diagnostic (CDx) certification under EU in vitro diagnostic regulation (IVDR)1 as a CDx test for colorectal cancer.
1 min
October 2025
Bio Spectrum
Aodh Lifesciences gets support from TDB to redefine pneumonia treatment
The Technology Development Board (TDB), Department of Science and Technology, Government of India, has extended support to Aodh Lifesciences, a startup based in Hyderabad, for development of Indigenous Antibiotic Nebulisation Suspension for Pneumonia (AONEUM-04) and Antimicrobial Resistance (AMR).
1 min
October 2025
Listen
Translate
Change font size